Recipients of the 2008 New Investigator Awards
This is the third year of competition for ATVB New Investigator Awards. The Awards recognize papers published in ATVB in 2007 that were submitted by new investigators and judged to be the most outstanding in the Atherosclerosis/Lipoprotein, Thrombosis, and Vascular Biology sections of the journal. The three awards are named for Dr Daniel Steinberg, who devised a method to determine the site of degradation of the proteins and lipids of a lipoprotein, which led to the concept of selective uptake of cholesterol and apoprotein that characterizes the reverse cholesterol transport pathway; Dr Karl Link, who identified dicoumarol as the hemorrhagic factor in spoiled sweet clover hay, and then developed dicoumarol and warfarin as anticoagulant drugs; and Dr Werner Risau, who formulated key concepts for the regulation of angiogenesis, challenged the prevailing dogmas about angiogenic factors, and proposed the now accepted hypothesis that several growth factors act sequentially to mediate vasculogenesis, angiogenesis, and vascular remodeling. We would like to point out that there are two award winners for the Dr Daniel Steinberg Award in Atherosclerosis/Lipoproteins for 2008. Both winners published similar findings related to the use of vaccination against the VEGF receptor 2 in attenuating the progression of atherosclerosis. These studies may have potential applications in the treatment of atherosclerosis.
In the third year of the award, 550 papers were submitted for the Awards. Recipients of the awards are:
Suzanne J.A. Korporaal, MD, University Medical Center Utrecht, the 2008 recipient of the Karl Link New Investigator Award in Thrombosis, for her paper “Platelet Activation by Oxidized Low Density Lipoprotein is Mediated by Cd36 and Scavenger Receptor-A” (Arterioscler Thromb Vasc Biol. 2007;27:2476–2483). ⇓
Arnaud D. Hauer, MSc, Leiden University, the 2008 recipient of the Daniel Steinberg New Investigator Award in Atherosclerosis/Lipoproteins, for his paper “Vaccination against VEGFR2 attenuates initiation and progression of atherosclerosis” (Arterioscler Thromb Vasc Biol. 2007;27:2050–2057). ⇓
Ramona Petrovan, PhD, The Scripps Research Institute, the 2008 recipient of the Daniel Steinberg New Investigator Award in Atherosclerosis/Lipoproteins, for her paper “DNA vaccination against VEGF receptor 2 reduces atherosclerosis in LDL receptor-deficient mice” (Arterioscler Thromb Vasc Biol. 2007;27:1095–1100). ⇓
Christopher P. Mack, University of North Carolina, the 2008 recipient of the Werner Risau New Investigator Award in Vascular Biology, for his paper “Diaphanous 1 and 2 Regulate Smooth Muscle Cell Differentiation by Activating the Myocardin-Related Transcription Factors,” (Arterioscler Thromb Vasc Biol. 2007;27:478–486). ⇓
The recipients will be honored at the 9th Annual Conference on Atherosclerosis, Thrombosis, and Vascular Biology, and will receive a plaque, travel support (provided by the ATVB Council), and a check for $2500, provided by Lippincott, Williams, and Wilkins.
The Editors congratulate the recipients of the Awards for their outstanding papers!